Is uptake of AS in low-risk prostate cancer in Ontario linked to guideline publication?
作者信息
Cooperberg Matthew R
机构信息
Department of Urology, UCSF, San Francisco, CA, United States.
出版信息
Can Urol Assoc J. 2025 Jun;19(6):165-166. doi: 10.5489/cuaj.9282.
Abstract
摘要
相似文献
1
Is uptake of AS in low-risk prostate cancer in Ontario linked to guideline publication?安大略省低风险前列腺癌中雄激素剥夺治疗（ADT）的使用与指南发布有关吗？
Can Urol Assoc J. 2025 Jun;19(6):165-166. doi: 10.5489/cuaj.9282.
2
Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline.前列腺癌的骨骼健康和骨靶向治疗：ASCO 对安大略癌症护理指南的认可。
J Clin Oncol. 2020 May 20;38(15):1736-1743. doi: 10.1200/JCO.19.03148. Epub 2020 Jan 28.
3
Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.主动监测在局限性前列腺癌管理中的应用（安大略癌症护理指南）：美国临床肿瘤学会临床实践指南的认可。
J Clin Oncol. 2016 Jun 20;34(18):2182-90. doi: 10.1200/JCO.2015.65.7759. Epub 2016 Feb 16.
4
Fractionation of Palliative Radiation Therapy for Bone Metastases in Ontario: Do Practice Guidelines Guide Practice?安大略省姑息性放射性治疗骨转移的分割：实践指南是否指导实践？
Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):31-39. doi: 10.1016/j.ijrobp.2015.07.2291. Epub 2015 Aug 3.
5
Melanoma nodal management in Ontario the year after the 2012 American Society of Clinical Oncology and Society of Surgical Oncology guideline.2012年美国临床肿瘤学会和外科肿瘤学会发布指南后的安大略省黑色素瘤淋巴结处理情况
Curr Oncol. 2019 Oct;26(5):330-337. doi: 10.3747/co.26.5123. Epub 2019 Oct 1.
6
Prostate cancer risk by occupation in the Occupational Disease Surveillance System (ODSS) in Ontario, Canada.加拿大安大略省职业病监测系统（ODSS）中的职业与前列腺癌风险。
Health Promot Chronic Dis Prev Can. 2019 May;39(5):178-186. doi: 10.24095/hpcdp.39.5.02.
7
American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer.美国临床肿瘤学会认可安大略癌症护理关于转移性激素难治性（去势抵抗性）前列腺癌男性非激素治疗的实践指南。
J Clin Oncol. 2007 Nov 20;25(33):5313-8. doi: 10.1200/JCO.2007.13.4536. Epub 2007 Oct 9.
8
9
Using real-world, population-level data to assess the uptake of active surveillance for low-grade prostate cancer before and after the release of clinical guidelines.利用真实世界的人群水平数据，评估临床指南发布前后低级别前列腺癌主动监测的采用情况。
Can Urol Assoc J. 2025 Jun;19(6):158-164. doi: 10.5489/cuaj.9019.
10
Management Strategies and Patient Selection After a Hospital Funding Reform for Prostate Cancer Surgery in Canada.加拿大前列腺癌手术医院资金改革后管理策略和患者选择
JAMA Netw Open. 2019 Aug 2;2(8):e1910505. doi: 10.1001/jamanetworkopen.2019.10505.
本文引用的文献
1
Using real-world, population-level data to assess the uptake of active surveillance for low-grade prostate cancer before and after the release of clinical guidelines.利用真实世界的人群水平数据，评估临床指南发布前后低级别前列腺癌主动监测的采用情况。
Can Urol Assoc J. 2025 Jun;19(6):158-164. doi: 10.5489/cuaj.9019.
2
Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020.2010 - 2020年对中危前列腺癌进行主动监测或观察等待
JAMA. 2024 Dec 17;332(23):2033-2036. doi: 10.1001/jama.2024.20580.
3
When is prostate cancer really cancer?
J Natl Cancer Inst. 2025 Mar 1;117(3):402-405. doi: 10.1093/jnci/djae200.
4
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage.前列腺腺癌中，预测转移风险的不良病理学（不利组织学）的优化定义建议，与分级分组和病理分期无关。
Histopathology. 2024 Oct;85(4):598-613. doi: 10.1111/his.15231. Epub 2024 Jun 3.
5
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.前列腺癌监测、手术或放疗后 15 年的结果。
N Engl J Med. 2023 Apr 27;388(17):1547-1558. doi: 10.1056/NEJMoa2214122. Epub 2023 Mar 11.
6
Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US.美国低危前列腺癌管理中主动监测应用的时间趋势和变化。
JAMA Netw Open. 2023 Mar 1;6(3):e231439. doi: 10.1001/jamanetworkopen.2023.1439.
7
The Impact of a Statewide Active Surveillance Initiative: A Roadmap for Increasing Active Surveillance Utilization Nationwide.一项全州范围主动监测计划的影响：提高全国主动监测利用率的路线图。
Eur Urol. 2023 Apr;83(4):307-310. doi: 10.1016/j.eururo.2022.05.028. Epub 2022 Jun 7.
8
Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US.美国低危前列腺癌主动监测的区域差异。
JAMA Netw Open. 2020 Dec 1;3(12):e2031349. doi: 10.1001/jamanetworkopen.2020.31349.
9
Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer.多参数磁共振成像单独检测不足以对前列腺癌主动监测的分级重新分类。
Eur Urol. 2020 Oct;78(4):515-517. doi: 10.1016/j.eururo.2020.06.030. Epub 2020 Jul 4.
10
Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden.瑞典极低危前列腺癌主动监测的应用。
JAMA Oncol. 2017 Oct 1;3(10):1393-1398. doi: 10.1001/jamaoncol.2016.3600.
Zotero 插件